The present invention describes methods and compositions for non-invasively assessing the molecular structure of biocompatible hydrogels using MRI analysis. It is shown that biocompatible hydrogels prepared from polymerizing macromolecules that are attached to a paramagnetic, superparamagnetic or ferromagnetic contrast agents form reporter gels wherein monitoring of the changes in the structure of the hydrogels by MRI is facilitated by the presence of such paramagnetic, superparamagnetic or ferromagnetic agents in the biocompatible hydrogel.

The present invention describes methods and compositions for non-invasively assessing the molecular structure of biocompatible hydrogels using MRI analysis. It is shown that biocompatible hydrogels prepared from polymerizing macromolecules that are attached to a paramagnetic, superparamagnetic or ferromagnetic contrast agents form reporter gels wherein monitoring of the changes in the structure of the hydrogels by MRI is facilitated by the presence of such paramagnetic, superparamagnetic or ferromagnetic agents in the biocompatible hydrogel.

The present invention relates to a device and a method. The device of the present invention comprising a patch comprising: a substrate, and an adhesive on the substrate. Further, the patch is configured to be attached to a skin via the adhesive to form a pocket between the patch and the skin, to allow introduction of a material into the pocket, and to hold the material within the pocket.

Medical gauze includes a warp knitted fabric having a warp and weft direction and composed of loops continued in the warp direction. The warp knitted fabric is made of 100% long fiber containing 70% by weight or more of regenerated cellulose-based long fiber. The warp knitted fabric is preferably configured in a marquisette construction. The regenerated cellulose-based long fiber is preferably cuprammonium rayon. Preferably having a width of equal to or greater than 5 mm and equal to or less than 600 mm, and a weight of equal to or greater than 28 g and equal to or less than 290 g per square meter. As the warp knitted fabric is composed of the loops continued in the warp direction and made of 100% long fiber containing 70% by weight or more of the regenerated cellulose-based long fiber, the occurrence of lint can be reduced to improve lint-free performance.

The invention relates to a paste for marking textile fabrics and/or other products incapable of x-ray contrast. The paste comprises the mineral materials barite (BaSO.sub.4) and halloysite. These substances have a ratio of four volume parts barite to one volume part halloysite. The invention also relates to a wound dressing. The wound dressing contains composite fibers and is provided with the paste described at the outset. The invention additionally relates to the use of this wound dressing for the care of wound lesions. The invention also relates to a method for applying the paste described at the outset to a textile fabric and/or other products. The paste is applied to a textile fabric and/or to a different product by means of a printing process.

The invention relates to a paste for marking textile fabrics and/or other products incapable of x-ray contrast. The paste comprises the mineral materials barite (BaSO.sub.4) and halloysite. These substances have a ratio of four volume parts barite to one volume part halloysite. The invention also relates to a wound dressing. The wound dressing contains composite fibers and is provided with the paste described at the outset. The invention additionally relates to the use of this wound dressing for the care of wound lesions. The invention also relates to a method for applying the paste described at the outset to a textile fabric and/or other products. The paste is applied to a textile fabric and/or to a different product by means of a printing process.

The filament and suture products disclosed are to be implanted in the body, having non re sorbable ingredients with absorbent qualities to disperse an antibiotic and strong enough to hold tissue securely but flexible enough to be printed or knotted. The products are biocompatible and consist of two dissimilar polymers having unmelted cellulose fiber. These dissimilar polymers and the unmelted fibers are densified by compression and the removal of moisture having fiber orientation and alignment, showing low levels of radiopacity. These products will have radiopacity in household units (HU) ranging from −200 to 200 HU and produce meshes, bone grafts, scaffolds or wound care products where bone bridging can be observed.

The filament and suture products disclosed are to be implanted in the body, having non re sorbable ingredients with absorbent qualities to disperse an antibiotic and strong enough to hold tissue securely but flexible enough to be printed or knotted. The products are biocompatible and consist of two dissimilar polymers having unmelted cellulose fiber. These dissimilar polymers and the unmelted fibers are densified by compression and the removal of moisture having fiber orientation and alignment, showing low levels of radiopacity. These products will have radiopacity in household units (HU) ranging from −200 to 200 HU and produce meshes, bone grafts, scaffolds or wound care products where bone bridging can be observed.

A dressing for treating a tissue site with negative pressure may include a manifold including a first surface and a second surface opposite the first surface, a first layer adjacent to the first surface and a second layer adjacent to the second surface, the first layer and the second layer each comprising a polymer film, a plurality of fluid restrictions in the polymer film adjacent to at least the first surface, and at least one x-ray detectable marker extending in a linear pattern along the dressing.

A dressing for treating a tissue site with negative pressure may include a manifold including a first surface and a second surface opposite the first surface, a first layer adjacent to the first surface and a second layer adjacent to the second surface, the first layer and the second layer each comprising a polymer film, a plurality of fluid restrictions in the polymer film adjacent to at least the first surface, and at least one x-ray detectable marker extending in a linear pattern along the dressing.